Lessons from the Women's Health Initiative: Primary prevention and gender health

CMAJ. Canadian Medical Association Journal

Volumn 167, Issue 4, 2002, Pages 361-362

  Day, Anna ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; CALCIUM; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; SEROTONIN UPTAKE INHIBITOR; VITAMIN D;

ADOLESCENCE; BONE MASS; BREAST CANCER; CANCER PREVENTION; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COLORECTAL CANCER; DEEP VEIN THROMBOSIS; DIET; DRUG EFFICACY; EXERCISE; FEMALE; GENDER; HEALTH; HEART PROTECTION; HIP FRACTURE; HORMONE SUBSTITUTION; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE; LOW FAT DIET; LUNG EMBOLISM; MENOPAUSE; MORBIDITY; NOTE; OSTEOPOROSIS; POSTMENOPAUSE; PRIMARY PREVENTION; RISK BENEFIT ANALYSIS; SMOKING; STROKE; SUICIDE; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION;

EID: 0036376710     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (9)

1. Risk and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial
2. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk
3. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease
4. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II)
5. Determinants of peak bone mass: Clinical and genetic analyses in a young female Canadian cohort
6. The Asthma in Canada Study: A gender analysis
7. Survival and mortality from lung cancer in a screened population, The Johns Hopkins Study
8. Pharmacotherapy for obesity - Do the benefits outweigh the risks?
9. Deliberate self-harm and antidepressant drugs: Investigation of a possible link